D. Dincol Et Al. , "A comparison of imipenem monotherapy versus cefoperazone/sulbactam plus amikacin combination treatment in febrile neutropenic cancer patients," CANCER JOURNAL - FRANCE , vol.11, no.2, pp.89-93, 1998
Dincol, D. Et Al. 1998. A comparison of imipenem monotherapy versus cefoperazone/sulbactam plus amikacin combination treatment in febrile neutropenic cancer patients. CANCER JOURNAL - FRANCE , vol.11, no.2 , 89-93.
Dincol, D., Arican, A., Aydin, F., Samur, M., Willke, A., Akbulut, H., ... Pamir, A.(1998). A comparison of imipenem monotherapy versus cefoperazone/sulbactam plus amikacin combination treatment in febrile neutropenic cancer patients. CANCER JOURNAL - FRANCE , vol.11, no.2, 89-93.
Dincol, D Et Al. "A comparison of imipenem monotherapy versus cefoperazone/sulbactam plus amikacin combination treatment in febrile neutropenic cancer patients," CANCER JOURNAL - FRANCE , vol.11, no.2, 89-93, 1998
Dincol, D Et Al. "A comparison of imipenem monotherapy versus cefoperazone/sulbactam plus amikacin combination treatment in febrile neutropenic cancer patients." CANCER JOURNAL - FRANCE , vol.11, no.2, pp.89-93, 1998
Dincol, D. Et Al. (1998) . "A comparison of imipenem monotherapy versus cefoperazone/sulbactam plus amikacin combination treatment in febrile neutropenic cancer patients." CANCER JOURNAL - FRANCE , vol.11, no.2, pp.89-93.
@article{article, author={D Dincol Et Al. }, title={A comparison of imipenem monotherapy versus cefoperazone/sulbactam plus amikacin combination treatment in febrile neutropenic cancer patients}, journal={CANCER JOURNAL - FRANCE}, year=1998, pages={89-93} }